期刊文献+

甲状腺乳头状微小癌术后复发的相关因素分析 被引量:11

Analysis of correlative factors for recurrence in the papillary thyroid microcarcinoma
在线阅读 下载PDF
导出
摘要 目的:研究影响甲状腺乳头状微小癌(PTMC)术后复发的相关临床病理学因素。方法:回顾性分析124例PTMC患者的临床资料,采用单因素及多因素分析,探讨PTMC相关临床病理因素与术后复发的相关性。结果:平均随访57(18~120)个月,复发率为10.5%(13/124),单因素分析显示肿瘤直径≥5 mm(P=0.013)、颈部淋巴结转移(P=0.001)、多发癌灶(P=0.007)及甲状腺包膜侵犯(P=0.000)与PTMC复发显著相关;多因素分析显示颈部淋巴结转移(P=0.001)、多发癌灶(P=0.007)及甲状腺膜包膜侵犯(P=0.000)与PTMC复发显著相关。结论:PTMC总体预后良好,但仍有较高的复发率,且复发与某些临床病理学因素显著相关,在决定手术方式时应充分考虑这些因素。 Objective: To evaluate the clinical and pathological factors affecting recurrence in Papillary thyroid microcarcinoma(PTMC).Methods: One hundred and twenty-four patients diagnosed as PTMC and surgically treated from January 1997 to December 2006,and clinical records were evaluated retrospectively by univariate and multivariate analyses.Results: Incidence of recurrent disease was 10.5% after 57 months mean follow-up(range 18~120).Univariate analysis detected that tumor≥5 mm in size(P=0.013),metastases in neck lymph nodes(P=0.001),presence of multifocal(P=0.007),and presence of capsular invasion(P=0.000),were related to recurrence By multivariate analysis,presence of metastases in neck lymph nodes(P=0.034),multifocal(P=0.013),and capsular invasion(P=0.004) were significantly related to tumor recurrence.Conclusion: Patients with PTMC have a favorable prognosis.Some clinical and pathological factors may correlate with recurrence of PTMC,appropriate treatment may be justified depending on the presence or absence of these risk factors.
出处 《中国现代普通外科进展》 CAS 2010年第12期970-973,共4页 Chinese Journal of Current Advances in General Surgery
关键词 甲状腺肿瘤 乳头状 微小癌 复发 Thyroid neoplasms·Carcinome papillary·Microcarcinoma·Recurrence
  • 相关文献

参考文献10

  • 1Hedinger C,Williams ED,Sobin LH,et al.Histologic typing of thyroid tumors[J].In International Histological Classification of Tumors,1988,11:1-18.World Health Organization,Geneva.
  • 2Chow SM,Law SC,Chan JK,et al.Papillary microcarcinoma of the thyroid-prognostic significance of lymph node metastasis and mul-tifocality[J].Cancer,2003,98(1):31-40.
  • 3Appetecchia M,Scarcello G,Pucci E,et al.Outcome after treatment of papillary thyroid microcarcinoma[J].J Exp Clin Cancer Res,2002,21(2):159-164.
  • 4Watkinson JC,Franklyn JA,Olliff JF.Detection and surgical treatment of cervical lymph nodes in differentiated thyroid cancer[J].Thyroid,2006,16(2):187-194.
  • 5Ito Y,Tomoda C,Uruno T,et al.Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid[J].World J Surg,2006,30(1):91-99.
  • 6Besic N,Pilko G,Petric R,et al.Papillary thyroid microcarcinoma:prognostic factors and treatment[J].J Surg Oncol,2008,97(3):221-225.
  • 7Baudin E,Travagli JP,Ropers J,et al.Microcarcinoma of the thyroid gland:the gustave-roussy institute experience[J].Cancer,1998,83(3):553-559.
  • 8Roti E,Rossi R,Trasforini C,et al.Clinical and histological characteristics of papillary thyroid microcarcinoma:Results of a retrospective study in 243 patients[J].J Clin Endocrinol Metab,2006,91(6):2171-2178.
  • 9侯刚,李晓梅,李道胜,李宁,叶红.桥本甲状腺炎合并甲状腺微小癌临床病理分析[J].实用癌症杂志,2008,23(3):286-287. 被引量:7
  • 10Chow SM,Law SC,Mendenhall WM,et al.Papillary thyroid carcinoma:prognostic factors and the role of radioiodine and external ra-diotherapy[J].Int J Radiat Oncol Biol Phys,2002,52(3):784-795.

二级参考文献9

共引文献6

同被引文献113

  • 1梁兆煜,谢学羿,张少锐,区小卫,李日焕,江浩,杨瑞亮.甲状腺良性疾病中微小癌的检出率及其病理特征[J].癌症进展,2004,2(6):487-489. 被引量:10
  • 2张海添,陆云飞,廖清华,林坚.甲状腺手术中显露喉返神经价值的Meta分析[J].中华普通外科杂志,2005,20(4):204-206. 被引量:173
  • 3卢崇亮,张显岚.甲状腺结节的诊治进展[J].中国普通外科杂志,2006,15(4):282-285. 被引量:14
  • 4牛丽娟,郝玉芝,周纯武.超声诊断甲状腺占位性病变的价值[J].中华耳鼻咽喉头颈外科杂志,2006,41(6):415-418. 被引量:117
  • 5肖仲贤,于杰,李留峥,李志庭,王宏武,向春明,左峻林.甲状腺乳头状微小癌36例临床分析[J].岭南现代临床外科,2007,7(1):35-36. 被引量:12
  • 6Pazaitou-panayiotou K, Capezzone M, Pacini F. Clinical features and therapeutic implication of papillary thyroid microcarcinoma[J]. Thyroid, 2007, 17(11):1085-1092.
  • 7J'eon SI, Kim E, Park JS, et al. Diagnostic benefit of thyroglobulin measurement in fine-needle aspiration for diagnosing metastatic cervical lymph nodes from papillary thyroid cancer: correlations with US features[J]. Korean J Radiol, 2009, 10(2):106-111.
  • 8Pelizzo MR, Boschin IM, Toniato A, et al. Papillary thyroid microcarcinoma(PTMC): prognostic factors, management and outcome in 403 patients[J]. Eur J Surg Oncol, 2006, 32(10): 1144-1148.
  • 9Piersanfi M, Ezzat S, Asa SL. Controversies in papillary microcarcinoma of the thyroid[J]. Endocr Pathol, 2003, 14(3): 183-191.
  • 10Baudin E, Travagli JP, Ropers J, et al. Microcarcinoma of the thyroid gland : the Gustave-Roussy Institute experience[J]. Cancer, 1998, 83(3):553-559.

引证文献11

二级引证文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部